SlideShare a Scribd company logo
Regulatory issues relating to the growing and
cultivation of cannabis for medicinal purposes
RACI Pharmaceutical Science Group (NSW)
Bill Turner, Head of the Office of Drug Control
28 March 2017
What is the Office of Drug Control?
• Part of the Health Products Regulation Group,
Department of Health
• Administers:
• Regulations 5, 5H and 5G of the Customs (Prohibited
Imports) Regulations 1956
• Regulations 10 and 10A of the Customs (Prohibited
Exports Regulations 1958
• The Narcotic Drugs Act 1967
02 The Medicinal Cannabis Framework
Import
Cultivation and
Production
Production is the
removal of the cannabis
from the cannabis plant
Medicinal cannabis
licence – can authorise
cultivation or
production or both
Cannabis research
licence – authorises
research into the
medicinal properties of
cannabis
Cannabis licence requirements
• Fit and Proper Persons test set out in legislation
• Must be of good character
• Must be financial
• Must have the capacity and capability to undertake a
cannabis cultivation business
• Must not have engaged in ‘conduct constituting a serious
offence’ in the past 10 years
• Must make appropriate security arrangements
• For a medicinal cannabis licence, must have a business
relationship with a licensed manufacturer
• For a cannabis research licence, must be undertaking
appropriate research
Manufacture
Manufacturing Licence –
GMP
Therapeutic Goods
Administration
Manufacturing Licence –
State and Territories
Manufacturing Licence –
Office of Drug Control –
Narcotic Drugs Act 1967
Manufacture licence requirements
• Fit and Proper Persons test set out in legislation
• Must be of good character
• Must be financial
• Must have the capacity and capability to undertake a
cannabis manufacture business
• Must not have engaged in ‘conduct constituting a serious
offence’ in the past 10 years
• Must make appropriate security arrangements
• Must be able to demonstrate that supply will be in
accordance with the Therapeutic Goods Act 1989
Import
Import Licence –
Regulation 5 of the
Customs (PI) Regulations
Import permission for
each consignment –
Regulation 5 of the
Customs (PI) Regulations
Import requirements
• Fit and Proper Persons test
• Licensing process is to determine if the applicant is a
suitable person to be importing and handling narcotic
substances
• Permitting process is the ‘international currency’ system –
an import permission indicates a country’s willingness to
import; this allows the exporting country to issue ‘export
permission’.
• In the international trading system, the import permission
and the export permission ‘marry up’ to track quantities
traded and prevent over-production
• Subject to record keeping requirements to ensure
appropriate use
Questions

More Related Content

What's hot

Administrative Order No. 2014-0034
Administrative Order No. 2014-0034Administrative Order No. 2014-0034
Administrative Order No. 2014-0034
Javis Von Onias
 
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
Dr.Lavanya- Laws pertaining to Ayurvedic drugs
Dr.Lavanya-  Laws pertaining to Ayurvedic drugsDr.Lavanya-  Laws pertaining to Ayurvedic drugs
Dr.Lavanya- Laws pertaining to Ayurvedic drugs
Dr.Lavanya .S.A
 
Labeling in pharmaceutical packaging
Labeling in pharmaceutical packagingLabeling in pharmaceutical packaging
Labeling in pharmaceutical packaging
Rohit kumar
 
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
sandeep bansal
 
New FDA of the Philippines
New FDA of the PhilippinesNew FDA of the Philippines
New FDA of the Philippines
Asian Food Regulation Information Service
 
drug inspector
drug inspectordrug inspector
drug inspector
sourabhkumarUIP
 
(15 mph104) cdsco & fda guidelines
(15 mph104) cdsco & fda guidelines(15 mph104) cdsco & fda guidelines
(15 mph104) cdsco & fda guidelines
Dishant shah
 
Drugs & cosmetics amendment bill 2013 major changes
Drugs & cosmetics amendment bill 2013 major changesDrugs & cosmetics amendment bill 2013 major changes
Drugs & cosmetics amendment bill 2013 major changes
Bhaswat Chakraborty
 
Good distribution practices for API's
Good distribution practices for API'sGood distribution practices for API's
Good distribution practices for API's
GMP EDUCATION : Not for Profit Organization
 
Who gmp compliance ppt
Who gmp compliance pptWho gmp compliance ppt
Who gmp compliance ppt
shrikant Deshmukh
 
Good Manufacturing Practices for Pharmaceuticals
Good Manufacturing Practices for PharmaceuticalsGood Manufacturing Practices for Pharmaceuticals
Good Manufacturing Practices for Pharmaceuticals
Prof. Dr. Basavaraj Nanjwade
 
central and state Regulatory bodies in India
central and state Regulatory bodies in Indiacentral and state Regulatory bodies in India
central and state Regulatory bodies in India
sonaliph
 
Overview Drug, Alternative Medicines, Medical Devices Registration in Pakistan
Overview Drug, Alternative Medicines, Medical Devices Registration in PakistanOverview Drug, Alternative Medicines, Medical Devices Registration in Pakistan
Overview Drug, Alternative Medicines, Medical Devices Registration in Pakistan
Muhammad Ali Jehangir
 
Policy Brief
Policy BriefPolicy Brief
Policy Brief
Pallavi Joshi
 
Schedule M-Jurisprudence
Schedule M-JurisprudenceSchedule M-Jurisprudence
Schedule M-Jurisprudence
Saiyam Agarwal
 
China new food safety law comprehensive compliance guidance part ii
China new food safety law comprehensive compliance guidance part iiChina new food safety law comprehensive compliance guidance part ii
China new food safety law comprehensive compliance guidance part ii
REACH24H Consulting Group
 
IIMPORT AND REGISTRATION AS PER DRUG AND COSMETIC ACT
IIMPORT AND REGISTRATION AS PER  DRUG AND COSMETIC ACT IIMPORT AND REGISTRATION AS PER  DRUG AND COSMETIC ACT
IIMPORT AND REGISTRATION AS PER DRUG AND COSMETIC ACT
Sagar Savale
 
Certification
CertificationCertification
New drug approval
New drug approvalNew drug approval
New drug approval
Suvarta Maru
 

What's hot (20)

Administrative Order No. 2014-0034
Administrative Order No. 2014-0034Administrative Order No. 2014-0034
Administrative Order No. 2014-0034
 
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
 
Dr.Lavanya- Laws pertaining to Ayurvedic drugs
Dr.Lavanya-  Laws pertaining to Ayurvedic drugsDr.Lavanya-  Laws pertaining to Ayurvedic drugs
Dr.Lavanya- Laws pertaining to Ayurvedic drugs
 
Labeling in pharmaceutical packaging
Labeling in pharmaceutical packagingLabeling in pharmaceutical packaging
Labeling in pharmaceutical packaging
 
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
 
New FDA of the Philippines
New FDA of the PhilippinesNew FDA of the Philippines
New FDA of the Philippines
 
drug inspector
drug inspectordrug inspector
drug inspector
 
(15 mph104) cdsco & fda guidelines
(15 mph104) cdsco & fda guidelines(15 mph104) cdsco & fda guidelines
(15 mph104) cdsco & fda guidelines
 
Drugs & cosmetics amendment bill 2013 major changes
Drugs & cosmetics amendment bill 2013 major changesDrugs & cosmetics amendment bill 2013 major changes
Drugs & cosmetics amendment bill 2013 major changes
 
Good distribution practices for API's
Good distribution practices for API'sGood distribution practices for API's
Good distribution practices for API's
 
Who gmp compliance ppt
Who gmp compliance pptWho gmp compliance ppt
Who gmp compliance ppt
 
Good Manufacturing Practices for Pharmaceuticals
Good Manufacturing Practices for PharmaceuticalsGood Manufacturing Practices for Pharmaceuticals
Good Manufacturing Practices for Pharmaceuticals
 
central and state Regulatory bodies in India
central and state Regulatory bodies in Indiacentral and state Regulatory bodies in India
central and state Regulatory bodies in India
 
Overview Drug, Alternative Medicines, Medical Devices Registration in Pakistan
Overview Drug, Alternative Medicines, Medical Devices Registration in PakistanOverview Drug, Alternative Medicines, Medical Devices Registration in Pakistan
Overview Drug, Alternative Medicines, Medical Devices Registration in Pakistan
 
Policy Brief
Policy BriefPolicy Brief
Policy Brief
 
Schedule M-Jurisprudence
Schedule M-JurisprudenceSchedule M-Jurisprudence
Schedule M-Jurisprudence
 
China new food safety law comprehensive compliance guidance part ii
China new food safety law comprehensive compliance guidance part iiChina new food safety law comprehensive compliance guidance part ii
China new food safety law comprehensive compliance guidance part ii
 
IIMPORT AND REGISTRATION AS PER DRUG AND COSMETIC ACT
IIMPORT AND REGISTRATION AS PER  DRUG AND COSMETIC ACT IIMPORT AND REGISTRATION AS PER  DRUG AND COSMETIC ACT
IIMPORT AND REGISTRATION AS PER DRUG AND COSMETIC ACT
 
Certification
CertificationCertification
Certification
 
New drug approval
New drug approvalNew drug approval
New drug approval
 

Similar to Presentation: Regulatory issues relating to the growing and cultivation of cannabis for medicinal purposes

narcotic drug law_for upload.pptx
narcotic drug law_for upload.pptxnarcotic drug law_for upload.pptx
narcotic drug law_for upload.pptx
akritikachroo
 
Irum naila
Irum nailaIrum naila
Irum naila
Kalim Ullah
 
Import and export of drugs in india
Import and export of drugs in indiaImport and export of drugs in india
Import and export of drugs in india
Ammar Tasleem
 
National Pharmaceutical Pricing Authority-WPS Office.pptx
National Pharmaceutical Pricing Authority-WPS Office.pptxNational Pharmaceutical Pricing Authority-WPS Office.pptx
National Pharmaceutical Pricing Authority-WPS Office.pptx
Sudipta Roy
 
CANNABIS INDUSTRY IN COLOMBIA 2018
CANNABIS INDUSTRY IN COLOMBIA 2018CANNABIS INDUSTRY IN COLOMBIA 2018
CANNABIS INDUSTRY IN COLOMBIA 2018
ProColombia
 
Business with medical cannabis
Business with medical cannabisBusiness with medical cannabis
Business with medical cannabis
Tatiana Behar Russy
 
Narcotic drugs & psychotropic substances act,1985 with rules 1985
Narcotic drugs & psychotropic substances act,1985 with rules 1985Narcotic drugs & psychotropic substances act,1985 with rules 1985
Narcotic drugs & psychotropic substances act,1985 with rules 1985
Ravikumar Patil
 
Legislation in respect of Homeopathic Pharmacy
Legislation in respect of Homeopathic PharmacyLegislation in respect of Homeopathic Pharmacy
Legislation in respect of Homeopathic Pharmacy
RamJyothis
 
Drug Regulations in India Dr Surinder Singh.pdf
Drug Regulations in India Dr Surinder Singh.pdfDrug Regulations in India Dr Surinder Singh.pdf
Drug Regulations in India Dr Surinder Singh.pdf
wasimankhan
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in India
Chandra Mohan
 
Cartilla_Cannabis_2023_ENG_FINAL.pdf
Cartilla_Cannabis_2023_ENG_FINAL.pdfCartilla_Cannabis_2023_ENG_FINAL.pdf
Cartilla_Cannabis_2023_ENG_FINAL.pdf
ProColombia
 
Adminstration of act and rules
Adminstration of act and rulesAdminstration of act and rules
Adminstration of act and rules
Dr. Supriya Suman
 
Adminstration of act and rules
Adminstration of act and rulesAdminstration of act and rules
Adminstration of act and rules
Dr. Supriya Suman
 
DI.pptx
DI.pptxDI.pptx
Drug trafficking and the role of ndps act in curbing the menace of organized ...
Drug trafficking and the role of ndps act in curbing the menace of organized ...Drug trafficking and the role of ndps act in curbing the menace of organized ...
Drug trafficking and the role of ndps act in curbing the menace of organized ...
gagan deep
 
406506068-NDPS-Act-1985-Ppt. By nitin agarwal
406506068-NDPS-Act-1985-Ppt. By nitin agarwal406506068-NDPS-Act-1985-Ppt. By nitin agarwal
406506068-NDPS-Act-1985-Ppt. By nitin agarwal
ShubhamKrSingh8
 
Pharmaceutical industry
Pharmaceutical industryPharmaceutical industry
Pharmaceutical industry
Apurv Singh
 
regulatory affairs ip ii final
regulatory affairs  ip ii finalregulatory affairs  ip ii final
regulatory affairs ip ii final
Audumbar Mali
 
Generic Products Registration: Egypt vs Saudi Arabia
Generic Products Registration: Egypt vs Saudi Arabia Generic Products Registration: Egypt vs Saudi Arabia
Generic Products Registration: Egypt vs Saudi Arabia
Abdallah M. Youssof
 
DRA1.pptx
DRA1.pptxDRA1.pptx
DRA1.pptx
Renu Lamba
 

Similar to Presentation: Regulatory issues relating to the growing and cultivation of cannabis for medicinal purposes (20)

narcotic drug law_for upload.pptx
narcotic drug law_for upload.pptxnarcotic drug law_for upload.pptx
narcotic drug law_for upload.pptx
 
Irum naila
Irum nailaIrum naila
Irum naila
 
Import and export of drugs in india
Import and export of drugs in indiaImport and export of drugs in india
Import and export of drugs in india
 
National Pharmaceutical Pricing Authority-WPS Office.pptx
National Pharmaceutical Pricing Authority-WPS Office.pptxNational Pharmaceutical Pricing Authority-WPS Office.pptx
National Pharmaceutical Pricing Authority-WPS Office.pptx
 
CANNABIS INDUSTRY IN COLOMBIA 2018
CANNABIS INDUSTRY IN COLOMBIA 2018CANNABIS INDUSTRY IN COLOMBIA 2018
CANNABIS INDUSTRY IN COLOMBIA 2018
 
Business with medical cannabis
Business with medical cannabisBusiness with medical cannabis
Business with medical cannabis
 
Narcotic drugs & psychotropic substances act,1985 with rules 1985
Narcotic drugs & psychotropic substances act,1985 with rules 1985Narcotic drugs & psychotropic substances act,1985 with rules 1985
Narcotic drugs & psychotropic substances act,1985 with rules 1985
 
Legislation in respect of Homeopathic Pharmacy
Legislation in respect of Homeopathic PharmacyLegislation in respect of Homeopathic Pharmacy
Legislation in respect of Homeopathic Pharmacy
 
Drug Regulations in India Dr Surinder Singh.pdf
Drug Regulations in India Dr Surinder Singh.pdfDrug Regulations in India Dr Surinder Singh.pdf
Drug Regulations in India Dr Surinder Singh.pdf
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in India
 
Cartilla_Cannabis_2023_ENG_FINAL.pdf
Cartilla_Cannabis_2023_ENG_FINAL.pdfCartilla_Cannabis_2023_ENG_FINAL.pdf
Cartilla_Cannabis_2023_ENG_FINAL.pdf
 
Adminstration of act and rules
Adminstration of act and rulesAdminstration of act and rules
Adminstration of act and rules
 
Adminstration of act and rules
Adminstration of act and rulesAdminstration of act and rules
Adminstration of act and rules
 
DI.pptx
DI.pptxDI.pptx
DI.pptx
 
Drug trafficking and the role of ndps act in curbing the menace of organized ...
Drug trafficking and the role of ndps act in curbing the menace of organized ...Drug trafficking and the role of ndps act in curbing the menace of organized ...
Drug trafficking and the role of ndps act in curbing the menace of organized ...
 
406506068-NDPS-Act-1985-Ppt. By nitin agarwal
406506068-NDPS-Act-1985-Ppt. By nitin agarwal406506068-NDPS-Act-1985-Ppt. By nitin agarwal
406506068-NDPS-Act-1985-Ppt. By nitin agarwal
 
Pharmaceutical industry
Pharmaceutical industryPharmaceutical industry
Pharmaceutical industry
 
regulatory affairs ip ii final
regulatory affairs  ip ii finalregulatory affairs  ip ii final
regulatory affairs ip ii final
 
Generic Products Registration: Egypt vs Saudi Arabia
Generic Products Registration: Egypt vs Saudi Arabia Generic Products Registration: Egypt vs Saudi Arabia
Generic Products Registration: Egypt vs Saudi Arabia
 
DRA1.pptx
DRA1.pptxDRA1.pptx
DRA1.pptx
 

More from TGA Australia

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
TGA Australia
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
TGA Australia
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
TGA Australia
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
TGA Australia
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
TGA Australia
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
TGA Australia
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
TGA Australia
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
TGA Australia
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
TGA Australia
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
TGA Australia
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA Australia
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
TGA Australia
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Australia
 

More from TGA Australia (20)

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 

Recently uploaded

Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 

Recently uploaded (20)

Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 

Presentation: Regulatory issues relating to the growing and cultivation of cannabis for medicinal purposes

  • 1. Regulatory issues relating to the growing and cultivation of cannabis for medicinal purposes RACI Pharmaceutical Science Group (NSW) Bill Turner, Head of the Office of Drug Control 28 March 2017
  • 2. What is the Office of Drug Control? • Part of the Health Products Regulation Group, Department of Health • Administers: • Regulations 5, 5H and 5G of the Customs (Prohibited Imports) Regulations 1956 • Regulations 10 and 10A of the Customs (Prohibited Exports Regulations 1958 • The Narcotic Drugs Act 1967
  • 3. 02 The Medicinal Cannabis Framework Import
  • 4. Cultivation and Production Production is the removal of the cannabis from the cannabis plant Medicinal cannabis licence – can authorise cultivation or production or both Cannabis research licence – authorises research into the medicinal properties of cannabis
  • 5. Cannabis licence requirements • Fit and Proper Persons test set out in legislation • Must be of good character • Must be financial • Must have the capacity and capability to undertake a cannabis cultivation business • Must not have engaged in ‘conduct constituting a serious offence’ in the past 10 years • Must make appropriate security arrangements • For a medicinal cannabis licence, must have a business relationship with a licensed manufacturer • For a cannabis research licence, must be undertaking appropriate research
  • 6. Manufacture Manufacturing Licence – GMP Therapeutic Goods Administration Manufacturing Licence – State and Territories Manufacturing Licence – Office of Drug Control – Narcotic Drugs Act 1967
  • 7. Manufacture licence requirements • Fit and Proper Persons test set out in legislation • Must be of good character • Must be financial • Must have the capacity and capability to undertake a cannabis manufacture business • Must not have engaged in ‘conduct constituting a serious offence’ in the past 10 years • Must make appropriate security arrangements • Must be able to demonstrate that supply will be in accordance with the Therapeutic Goods Act 1989
  • 8. Import Import Licence – Regulation 5 of the Customs (PI) Regulations Import permission for each consignment – Regulation 5 of the Customs (PI) Regulations
  • 9. Import requirements • Fit and Proper Persons test • Licensing process is to determine if the applicant is a suitable person to be importing and handling narcotic substances • Permitting process is the ‘international currency’ system – an import permission indicates a country’s willingness to import; this allows the exporting country to issue ‘export permission’. • In the international trading system, the import permission and the export permission ‘marry up’ to track quantities traded and prevent over-production • Subject to record keeping requirements to ensure appropriate use